Arasaratnam, Punitha
Sadreddini, Masoud
Yam, Yeung
Kansal, Vinay
Dorbala, Sharmila
Di Carli, Marcelo F.
Beanlands, Rob S.
Merhige, Michael E.
Williams, Brent A.
Veledar, Emir
Min, James K.
Chen, Li
Ruddy, Terrence D.
Germano, Guido
Berman, Daniel S.
Shaw, Leslee J.
Chow, Benjamin J. W.
Funding for this research was provided by:
Astellas Pharma Global Development; Bracco Diagnostics, Inc.
National Heart, Lung, and Blood Institute grant (K23HL092299)
Heart and Stroke Foundation of Ontario (PRG6242)
Article History
Received: 24 July 2017
Accepted: 6 November 2017
First Online: 27 November 2017
Compliance with ethical standards
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.”
: This study was supported in part by an unrestricted grant from Astellas Pharma Global Development; Bracco Diagnostics, Inc.; a National Heart, Lung, and Blood Institute grant (K23HL092299), and a program grant from the Heart and Stroke Foundation of Ontario (PRG6242). Dr. Dorbala has received research grants from Astellas Pharma and owns General Electric stocks. Dr. Di Carli has received research grants from Toshiba. Dr. Merhige has served on Speakers’ Bureaus for Bracco Diagnostics, has received honoraria from the Positron Group, and served as medical director for the Positron Group. Dr. Williams is an employee of Geisinger Health System. Dr. Berman has received research grants from Lantheus Medical Imaging, Siemens, and Cardium Therapeutics, Inc.; has received honoraria from Spectrum Dynamics; has served on advisory boards for Bracco Diagnostics; and has received royalties from Cedars-Sinai Software. Dr. Beanlands is a career investigator supported by the Heart and Stroke Foundation of Ontario and Tier 1 Chair in Cardiovascular Research supported by the University of Ottawa. He is a consultant for Lantheus Medical Imaging and JubilantDRAXImage (JDI) and has received grant funding from GE Healthcare, Lantheus Medical Imaging, and JDI. Dr. Shaw has received research grants from Astellas Pharma and Bracco Diagnostics. Dr. Ruddy has received research grants from GE Healthcare and Advanced Accelerator Applications International. Dr. Chow receives research and fellowship training support from GE Healthcare and educational support from TeraRecon Inc. and holds the Saul and Edna Goldfarb Chair in Cardiac Imaging Research. The rest of the authors have no conflict of interest to disclose.